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CONCLUSIONS AND FUTURE RESEARCH
AIM 
The Potential Contribution of Medicines to Falls 
in  Older Persons and the Acceptance of 
Pharmacist Intervention 
Richardson M1, O’Dwyer C1, Gaskin J1, Conyard E1, Murphy K2
Pharmacy Department Our Lady of Lourdes Hospital Drogheda1, 
School of Pharmacy, University College Cork, Ireland2
1. Examine FRID use in older persons presenting with falls at Our Lady of
Lourdes Hospital Drogheda (OLOL) in the Republic of Ireland,
2. Investigate acceptance of CP intervention in reducing FRIDs.
• Falls account for 10-15% of acute hospital presentations in patients ≥60
years and cause >50% of injury-related hospitalisations.
• The cost of falls treatment in Ireland will double in next 10 years from
€0.9 - 1.1 billion in 2020 to €1.6 - 2.0 billion by 2030 (1). Reduced
quality of life, fear of future falls and decreased physical activity can
persist long after discharge.
• Polypharmacy & medicine choice are modifiable fall risks in older
patients; medicines known to increase fall risk are Fall Risk Increasing
Drugs (FRIDs) (1-5) e.g. benzodiazepines and antihypertensives.
• Clinical Pharmacists (CPs) can reduce the risk of falls by managing
polypharmacy and FRID prescribing as part of multidisciplinary
management of older patients (6-9).
Acute admissions records in the Emergency Department (ED) & Acute
Medical Assessment Unit (AMAU) of OLOL were searched daily for
eligible patients (Table 1) between June 1st and July 13th 2018.
Table 1: Inclusion and Exclusion Criteria
Informed consent was sought from the patient or next of kin. The CP
provided routine care service to included participants: (i) medication
reconciliation, (ii) review of observations, (iii) review of renal and hepatic
function, and (iv) review of prescribed medicines for polypharmacy,
duplication of therapy, interactions & patient-specific medicine
appropriateness.
CP recommendations focused on the top five classes of FRIDs based on a
meta-analysis by Woolcott et al (10).
Medical records were reviewed between July 16th and 20th 2018 to
determine the extent of recommendation implementation. Data was
analysed using Microsoft Excel.
Polypharmacy:
➢77% of those recruited were on ≥5 medicines on admission
➢32 % of those recruited were on ≥10 medicines on admission.
➢100% of patients prescribed benzodiazepines, sedatives and antipsychotic medicines were
on ≥5 medicines on admission .
➢94% of those on antidepressants were on ≥5 medicines on admission.
➢76% of those prescribed antihypertensives were on ≥5 medicines on admission.
On review 83% of patients were on ≥5 medicines. The increase in the number of medicines
was predominantly due to analgesics and laxatives. 47.2 % had in increase in the number of
medicines prescribed, 20.8% of patients had a reduction in the number of medicines
prescribed, while 32.1% were unchanged. It would have been desirable to review patients at
a later point when analgesia and laxatives and acute medicines had ceased.
Classes of Medicines:
Table 2: Medicine Classes per Patient on Admission
➢94.3% of patients on ≥ 1 FRID on admission
➢Total of 83 antihypertensive agents prescribed to 42 patients on admission
➢ On review, there was a reduction of 15 antihypertensive agents prescribed with 10
diuretics ceased.
➢One sedative was stopped and two benzodiazepines were stopped while a further three
patients had their benzodiazepine dose reduced with a view to cessation, however the
process had not been completed at the time of review. Cessation of sedatives and
benzodiazepines has to be completed slowly in a stepwise manner to minimise patient
distress.
There was no reduction in the prescribing of antipsychotics and an increase of two patients
prescribed antidepressants.
Role of the Clinical Pharmacist:
Clinical Pharmacists made recommendations for changes to patients medicines aimed at
reducing the risk of future falls. The recommendations were reviewed by the patients
medical team and discussed with the Clinical Pharmacist if necessary.
• 41.7% of recommendations were fully actioned.
• FROR was reduced for benzodiazepines, diuretics, ACE inhibitors and Angiotensin
Receptor Blockers.
• FROR was increased for antidepressants and unchanged for other classes of medicines.
• The reduction in the FROR was not statistically significant (p=0.22).
Male Female Total %
Antihypertensives 22 20 42 79.2%
Antidepressants 5 11 16 30.2%
Benzodiazepines 3 4 7 13.2%
Antipsychotics 0 1 1 1.9%
Neuroleptics 0 0 0 0
Sedatives 4 2 6 11.3%
Inclusion Criteria ≥65 years , acute fall presentation
Exclusion Criteria ≤65 years , non-acute fall presentation, fall as an inpatient, not on any 
regular prescribed medicine
Clinical Pharmacists have a key role to play in identifying and managing polypharmacy and FRIDs in older patients. CPs can contribute to the multidisciplinary team in
medicines management and reducing the risk of future falls in older patients. Reducing falls incidence ensures better quality of life, reduced acute hospital admissions in a
stretched healthcare system. There is scope for significant future research in this area including: longer follow-up period for patients after CP review and review after
discharge from hospital to determine if suggested changed to medicines have been implemented and sustained. CPs can have input in development of education programmes
for prescribers to highlight FRIDs and polypharmacy in older patients at risk of falls. There is CP involvement in development of a Falls Prevention Policy in the North-
Eastern HSE area and in HSE Falls Collaborative research as a result of this research.
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